Edgewise Therapeutics has a one year low of $14.90 and a one year high of $38.12. The firm has a market cap of $2.53 billion, a price-to-earnings ratio of -17.81 and a beta of 0.20.

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Edgewise Therapeutics (EWTX – Research Report) and Walgreens Boots Alliance (WBA – Research Report).

This issue’s “Books” column includes “The Old Man and the Queer,”a non-fiction account of whose subtitle, “The Transformative Story of a Retired Mayor and the Barber Who Freed Him From Bigotry,” gives ...

After hours: March 6 at 4:52:59 PM EST Loading Chart for EWTX ...